Molecular Pharmacology | Income Statement
Fiscal year is July-June. All values USD Thousands.
2010
2011
2012
2013
2014
Cost of Goods Sold (COGS) incl. D&A
0.70
0.60
-
0.20
0.00
Gross Income
0.70
0.60
-
0.20
0.00
SG&A Expense
71.70
121.30
171.80
208.90
116.90
EBIT
117.20
121.90
179.40
209.10
116.90
Unusual Expense
-
-
-
0.80
-
Pretax Income
117.20
121.90
179.40
209.90
116.90
Consolidated Net Income
117.20
121.90
179.40
209.90
116.90
Net Income
117.20
121.90
179.40
209.90
116.90
Net Income After Extraordinaries
117.20
121.90
179.40
209.90
116.90
Net Income Available to Common
117.20
121.90
179.40
209.90
116.90
EPS (Basic)
0.00
0.00
0.00
0.00
0.00
Basic Shares Outstanding
111,553.70
111,553.70
111,553.70
111,553.70
111,553.70
EPS (Diluted)
0.00
0.00
0.00
0.00
0.00
Diluted Shares Outstanding
111,553.70
111,553.70
111,553.70
111,553.70
111,553.70
EBITDA
116.50
121.30
178.90
208.90
116.90
Other Operating Expense
44.80
-
7.10
-
-
About Molecular Pharmacology
View Profile
